Russian President Vladimir Putin can continue funding the war in Ukraine for several more years despite rising economic strain, former Russian central bank deputy chairman Sergey Aleksashenko told CNBC on Friday. Aleksashenko noted that the Bank of Russia expects just…
Semiconductor stocks slid broadly on Friday after Broadcom Inc.’s (NASDAQ:AVGO) cautious profitability outlook punctured confidence in the AI-fueled chip rally. Nvidia Corp. (NASDAQ:NVDA), Advanced Micro Devices, Inc. (NASDAQ:AMD), Marvell Technology, Inc. (NASDAQ:MRVL), Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM), Micron Technology…
Abivax SA’s (NASDAQ:ABVX) stock is trading higher on Wednesday. The stock reacted to market rumours that U.S. pharma giant Eli Lilly and Co (NYSE:LLY) could make an offer. • Abivax stock is charging ahead with explosive momentum. Check out ABVX…
HeartBeam, Inc.’s (NASDAQ:BEAT) stock is trading higher on Monday, with a session volume of 193.38 million compared to the average volume of 2.191 million as per data from Benzinga Pro. On Wednesday, the U.S. Food and Drug Administration (FDA) granted…
Alpha Tau Medical Ltd. (NASDAQ:DRTS) shares climbed 25.26% in after-hours trading to $5.30, after the company announced the first patient treatment in its pilot study for recurrent glioblastoma multiforme using its Alpha DaRT alpha-radiation cancer therapy. Check out the current…
On Tuesday, Senti Biosciences, Inc. (NASDAQ:SNTI) shared new data from its ongoing trial of SENTI-202, a first-in-class CD33/FLT3 targeting Logic Gated CAR NK cell therapy in patients with relapsed or refractory Acute Myeloid Leukemia. Senti Biosciences shares are retreating from…
Elon Musk‘s satellite internet company Starlink clarified Monday that subscription fees for its service in India have not been set and orders are not open, following a brief website glitch that showed dummy pricing. The company’s website earlier showed a…
Dyne Therapeutics, Inc. (NASDAQ:DYN) on Monday revealed topline results from the Registrational Expansion Cohort (REC) of its Phase 1/2 DELIVER trial evaluating zeleciment rostudirsen (z-rostudirsen, also known as DYNE-251) for Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping. The…
Ocular Therapeutix Inc. (NASDAQ:OCUL) stock surged on Monday after the company announced plans to accelerate the timeline for submitting a New Drug Application (NDA) for Axpaxli (OTX-TKI) in the treatment of wet age-related macular degeneration (wet AMD). The company intends…
Eli Lilly and Co. (NYSE:LLY) announced that its diabetes drug, Mounjaro, will be added to China’s state-run health insurance scheme from January 1, 2026. Mounjaro Added to China Reimbursement List The inclusion of Mounjaro on China’s national reimbursement list, as decided by its…